Alnylam Pharmaceuticals, Inc. drugs

4 results
  • amvuttra - vutrisiran injection

    (Vutrisiran)
    Alnylam Pharmaceuticals, Inc.
    Amvuttra treats nerve damage (polyneuropathy) caused by hereditary transthyretin-mediated amyloidosis in adults. It also treats heart muscle disease (cardiomyopathy) caused by wild-type or hereditary transthyretin-mediated amyloidosis in adults, reducing risk of cardiovascular death, hospitalization, and urgent heart failure visits.
  • onpattro - patisiran injection, lipid complex

    (Patisiran)
    Alnylam Pharmaceuticals, Inc.
    Onpattro treats polyneuropathy caused by hereditary transthyretin-mediated amyloidosis in adults.
  • oxlumo - lumasiran injection, solution

    (Lumasiran)
    Alnylam Pharmaceuticals, Inc.
    OXLUMO treats primary hyperoxaluria type 1 (PH1) in pediatric and adult patients to lower urinary and plasma oxalate levels.